Table 2.

Clinical and biological characteristics of patients with IgG deposits (group 1)

No.	Gender	Disease					Biology
		age at onset of disease, years	first-signs diagnosis delay, weeks	Kidney only	multiorgan involvement	BVAS	eGFR (MDRD), mL/min/1.73 m2	serum creatinine, µmol/L	Pu, g/L	Pu, g/24 h	antibodies (PR3/MPO)
1	M	48	60	yes	no	12	23	253	16.1	16.6	MPO
2	M	48	14	no	no	15	53	133	0.6	ND	MPO
3	M	59	3	yes	no	12	15	380	1.87	4.54	MPO
4	M	36	1	no	no	14	23	288	4.82	7.71	MPO
5	M	53	52	no	no	20	16	370	5.34	7	MPO
6	F	48	2	yes	yes	22	7	626	1.17	0.88	MPO
7	M	60	8	yes	no	19	14	412	4.61	7.8	MPO
8	F	32	12	no	yes	16	12	388	0.84	2.02	MPO
9	M	74	NA	yes	no	12	19	297	1.09	1.72	MPO
10	M	55	24	yes	no	12	25	245	3.41	ND	MPO
11	F	55	364	no	no	15	33	152	1.66	0.89	MPO
12	M	69	4	yes	no	14	5	925	1.2	0.31	MPO
13	M	53	8	yes	no	12	24	259	1.41	2.82	MPO
14	F	80	1	yes	no	12	18	242	3.9	4.28	MPO
15	F	20	14	no	yes	21	18	294	2.14	1.28	MPO
16	M	51	4	no	yes	21	24	263	1.27	1.27	PR3
17	M	62	3	no	no	19	7	715	0.91	0.25	PR3
18	F	30	24	no	yes	17	55	108	0.25	0.78	MPO

BVAS, Birmingham Vascular Activity Score; eGFR, glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; Pu, proteinuria; MPO, myeloperoxidase; PR3, proteinase 3; NA, not available; ND, not determined.